Background: Schistosomiasis is a major parasitic disease, increasingly imported into temperate climates by immigrants from and travelers to endemic areas.
Schistosomiasis is a major helminthic disease of widespread endemicity in the tropics and subtropics. With approximately 200 million people in 74 countries i n f e c t e d , its prevalence as a human parasitic disease ranks second behind malaria. 1, 2 Due to an increasing number of trave l e rs and changing patterns of travel activities while a b ro a d , schistosomiasis imported to nonendemic areas is no longer almost exclusively seen as chronic infection in immigrants from endemic areas but also in increasing f i g u res as a c u t e 1 , 3 -9 and chronic condition 1 , 7 , 1 0 -1 2 in re t u rning trave l e rs who exposed themselves to contaminated freshwater.
Because of lack of surveillance data on imported cases of infectious diseases in Europe, the European Network on Imported Infectious Diseases Surveillance (Trop N e t E u rop) was founded in 1999 as an electronic netwo r k of clinical sites related to imported infectious diseases. Objectives and structure of the network have been described in detail elsewhere. 13, 14 The capacity of the network to detect outbreaks has been demonstrated b e f o re. 1 5 This re p o rt summarizes data from the first 3 ye a rs of sentinel surveillance for imported schistosomiasis.
Patients, Materials, and Methods
Member sites of the Tro p N e t E u rop netwo r k covered approximately 51,000 patients per year in the study period in 1999 to 2001, during which 22 sites within the network re p o rted 412 patients with a diagnosis of schistosomiasis. For every patient, the final diagnosis was qualified by the reporting center as either probable, suspected, or confirmed. For a diagnosis of confirmed schistosomiasis, pathogen detection (i.e., egg detection in urine, semen,stool,or biopsy material) was required. For a probable d i a g n o s i s , i m mu n og l o bulin G (IgG) detection by indire c t hemagglutination (IHA), f l u o re s c e n c e antibody test (FAT),or enzyme-linked immunosorbent a s s ay (ELISA) was used. Suspected cases we re those with unambiguous clinical/imaging evidence but lack of c o n f i rm a t o ry laboratory results at the time of re p o rt i n g . This applies particularly to the high number of patients presenting with signs and symptoms suggestive of acute s c h i s t o s o m i a s i s . In this early phase of disease, egg detection is frequently not possible.
A standardized and anonymous questionnaire was used for data submission. Reported individuals were classified according to patient characteristics (immigr a n t s , refugees, and foreign visitors from endemic areas to E u ro p e ; and students, t o u ri s t s , business trave l e rs ,e x p a t ri a t e s , military, and missionaries from Europe);and for reason for travel (e. g . ,t o u ri s m , bu s i n e s s ,i m m i gr a t i o n , re s e a rc h / education, missionary/volunteer/humanitarian aid, or visiting relatives/friends). Travel and case histories were analyzed for clinical and epidemiologic features of the infection. Presenting symptoms were analyzed, taking multiple entries by patients into account. I n d ividual data points were stored in a computerized database (Access, Microsoft,Redmond, WA) and were analyzed by SAS 8.01 (SAS Institute Inc. ,C a ry, N C, U S A ) . For categori c a l d a t a , Wald chi-square tests and for continuous data, M a n nWhitney U tests were performed.
Results
Of the 412 patients with a reported diagnosis of s c h i s t o s o m i a s i s , 299 (72.6%) we re re p o rted as confirm e d cases,according to the definitions used by the network. Further, 34 (8.3%) were classified as probable and 27 (6.6%) as suspected cases.Sixteen (3.9%) were classified as status post (i.e., clinical and laboratory results were suggestive of a past episode of schistosomiasis that was successfully cure d ) . For 36 individuals (8.7%), i n f o rm a t i o n on the final diagnosis was not obtainabl e.In the follow i n g analysis, only the 333 cases classified as confirmed and p ro b a ble have been included.Basic demographic data are given in Table 1 . Patient group (European versus NonEuropean origin) characteristics differed statistically significantly except for sex.Ta ble 2 shows the fre q u e n c y of schistosomiasis diagnoses by TropNetEurop member country and patient origin. Table 3 displays the region of infection by patient origin. Not surprisingly, the overwhelming majority of infections we re contracted in Africa,with West Africa as the single region with most infections.The five largest contributors at country level we re Malawi (48 patients; 1 4 . 4 % ) , Ghana (45;1 3 . 5 % ) ,M a l i ( 2 7 ;8 . 1 % ) , Burkina Faso (19; 5 . 7 % ) , and Egypt (15; 4 . 5 % ) .
N i n e t y -t wo cases we re clearly attri bu t a ble to S chistosoma haematobium,130 cases we re clearly attri bu t a bl e to Schistosoma mansoni, and 4 to Schistosoma intercalatum. Infections with Schistosoma japonicum or Schistosoma mekongi were not explicitly stated.No mixed infections were recorded.Given the spatial distribution of acquisition of infections, only a minority of cases was pro b a bl y due to these species,that remained unrevealed among the 107 cases for which the diagnosis was not broken down to species level.Thirty-six schistosomiasis patients were coinfected with malaria. These were excluded from symptom analysis. In the two subgroups of patients with specified symptoms, or absence of symptoms,re s p e c t ive l y (179 symptomatic individuals in total;90 of European, 89 of non-European ori gi n ) , the most common pro bl e m s were fever and diarrhea.Genitourinary symptoms were exclusively attributable to S. haematobium. Fatigue, skin involvement, and headache were among the next f requently encountered signs and symptoms. A b d o m i n a l pain was the predominant symptom among those 65 miscellaneous events named in both groups (24 of 39 specified episodes). A synopsis of signs and symptoms of these patients and a calculation of the statistical significance of differences between both patient groups is g iven in Table 4 . Clinical complications of schistosomiasis we re explicitly stated for 6 patients, for example, ectopic granulomas in spinal cord with neurologic complications (n=2 ) , hy d ro n e p h rosis of left kidney (n=1 ) , l iver cirrhosis (n=1 ) ,p rolonged bloody diarrhea (n=1 ) , and reactive arthritis (n=1).Of those 297 patients with schistosomiasis only (36 patients with Plasmodium spp coinfection excluded),240 (80.8%) were treated as outp a t i e n t s ,w h e reas 53 (17.8%) individuals re q u i red hospital admission (no data: n=4,1.3%).There were no deaths attributable to schistosomiasis reported in our patient c o l l e c t ive. All patients we re treated with praziquantel, o f which only 2 were explicitly reported as having drugrelated side effects (1 generalized skin rash following treatment;1 with nausea following medication).Again, underreporting is likely to have occurred,as there is no e s t a blished standard in use with our concise re p o rting tool, which would allow for comparing severity of adverse events.No patient received oxamniquine for S. mansoni or metrifonate for S. haematobium. Reporting of followups to the network was not done routinely. 
Discussion
A detailed update of the cur rent global epidemiol ogic schistosomiasis situation has been recently give n , 1 6 and the current concepts of schistosomiasis control have been reviewed. 17 The pattern of countries, or regions w h e re i m m i grants and tourists contracted schistosomiasis d i f f e rs significantly from the spatial distribution of schistosomiasis foci in endemic areas. For example, the size of the major focus in Egypt along the Nile River is not reflected in our cohort in terms of figures of import e d disease. Overestimates within a sentinel system striving for detection of epidemiologic trends of a condition that is frequently encountered in endemic countries but infrequently diagnosed as imported disease may arise from a single group of travelers or immigrants. Steady figures of high infection rates from particular areas,such as Dogon country in Mali and Lake Tanganyika in Malawi, reflect the elevated risk for the specific type of adventure traveler who is either uninformed, or, more frequently, deliberately takes risks, 6 such as freshwater exposure. In turn,underestimates appear to arise mainly from the lack of touristic attractiveness of some highly endemic regions,or political instabilities,thus defraying tourist activities. The absolute figures of imported schistosomiasis show large differences between sentinel countries.This is due to the absolute population figures and the number of contributing centers. With regard to i m m i gr a n t s , political conditions and terms of immigr a t i o n f rom endemic areas into va rious European countries are the fa c t o rs mainly re s p o n s i ble for the distri bution pattern of schistosomiasis imported into Europe. Whereas upto-date epidemiologic data are ava i l a ble for many endemic areas,true estimates of risks of infection are difficult to obtain. This is partially due to the fact that reliable denominators are difficult to define. Although this has been tried with va rious appro a c h e s , 7 , 1 8 re l i a ble figures on t r ave l e rs exposed are lacking. H oweve r, the data obtained with the Tro p N e t E u rop sentinel surveillance system offer a unique tool to monitor changes of the absolute nu m b e r of cases imported from every endemic country and therefore might function as a warning system.They are of use to aid accurate and timely diagnosis and tre a t m e n t of both returning tourists and immigrants as well.
In studies of imported schistosomiasis,a bias in favo r of symptomatic individuals is to be expected. 1 9 The high number of nonsymptomatic patients in our records is consistent with previous findings. 1 , 7 In general, s y m p t o m analysis pointed neither toward a sensitive nor a specific sign indicative of schistosomiasis.
Symptoms possibly associated with Katayama fever (fever, diarrhea, fatigue, pulmonary and musculoskeletal s y m p t o m s ,h e a d a c h e,abdominal pain,and vomiting) we re reported more frequently among Europeans compared with non-Euro p e a n s . The high pro p o rtion of Euro p e a n s presenting with acute disease is not unexpected,as most short-term travelers tend to present early in the course of disease, w h e reas chronic stages are predominantly found in patients from endemic areas.However, some of these f e a t u re s , such as fa t i g u e,( bloody) diarr h e a , and abdominal discomfort, might also occur in patients with chronic d i s e a s e. N eve rt h e l e s s , our data suggest that a considerabl e p ro p o rtion of patients ori ginating from endemic areas also presented with acute disease. Apart from patients with S. japonicum infections, acute disease is not frequently observed in endemic areas, thus suggesting that these patients were nonimmune. Uncommon manifestations of schistosomiasis are n e u ro l ogic manifestations predominantly in the spinal cord t i s s u e. Although only anecdotally described in re t u rn i n g t r ave l e rs , 2 0 -2 2 50% of the few re p o rted complications in our cohort we re attri bu t a ble to neuro s c h i s t o s o m i a s i s .
Among the centers contri buting to Tro p N e t E u ro p, a wide range of diagnostic means for acute, chronic, and past schistosomiasis,including various parasitologic methods for egg demonstration, antibody, and antigen detection 23 is in use both for routine diagnostic and research purposes. To harmonize diagnostic criteria,the a b ove given definitions we re strictly applied to all re p o rt e d cases, resulting in 61 (14.8%) cases of both suspected (diagnosis based solely on clinical evidence) and pro b a bl e (diagnosis based on both clinical and sero l ogic ev i d e n c e ) cases at the time of re p o rt i n g .W h e reas this standard wa s chosen to maintain a high level of certainty on the corre c t d i a g n o s i s , it has been shown before in imported schistosomiasis that sero l ogy alone can reach up to 96% sensitiv i t y and high specificity compared with the gold standard of d i rect egg detection, 2 4 t h u s , being an acceptable scre e n i n g test in nonendemic areas for active and past infection.
Praziquantel is the drug of choice for the tre a t m e n t of schistosomiasis. [25] [26] [27] [28] This finds its reflection in our network data,with all patients having been treated with p r a z i q u a n t e l . Jelinek and colleagues found 6 of 62 trave l e rs who contracted schistosomiasis relapsing within 12 months after administration of praziquantel therapy. 7 Whitty and colleagues found a definite fa i l u re rate of 1.3% and a possible praziquantel failure rate of 2.9% in 550 schistosomiasis patients in London who were followed up for between 3 months to 2 ye a rs after tre a t m e n t . 1 Fo r the schistosomiasis patients reported to our network b e t ween 1999 and 2001, only few treatment fa i l u res have been reported until April 2002; namely, 3 patients of a s e ries of 5 patients with Katayama fever who relapsed after praziquantel treatment.Definite or suspected tre a t m e n t fa i l u res of later stages of schistosomiasis have not been re p o rted until A p ril 2002. We understand that this might reflect the difficulty in long-term follow-up of patients within the framework of this sentinel surveillance netwo r k rather than a 100% long-term treatment efficacy.
Schistosomiasis is a nonnotifiable disease in our E u ropean partner countri e s . Tro p N e t E u rop as a sentinel surveillance system has the capacity to facilitate better u n d e rstanding of epidemiology and clinical characteri s t i c s of imported schistosomiasis and provides va l u a bl e i n f o rmation to improve both pre t r avel advice and clinical practice. Since membership is self-selected,it is evident that the network cannot provide a representative data collection throughout Euro p e.H oweve r,in most Euro p e a n c o u n t ries medical services for immigrants and re t u rn i n g travelers are offered primarily at specialized centers.It is the only clinical network that collects data on imported infectious diseases on a European level that adds muchneeded information on epidemiologic changes in afflicted a reas in times of increasing travel activity and migr a t i o n .
